[3H]PNU-101958, a D4 dopamine receptor probe, accumulates in prefrontal cortex and hippocampus of non-human primate brain

Synapse

Volumn 37, Issue 3, 2000, Pages 232-244

  De La Garza II, Richard ^a   Madras, Bertha K ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Autoradiography; Clozapine; D4 dopamine receptors; L 745,870; Monkeys; PNU 101958

Indexed keywords

3 [[4 (4 CHLOROPHENYL) 1 PIPERAZINYL]METHYL] 1H PYRROLO[2,3 B]PYRIDINE; CLOZAPINE; DOPAMINE 4 RECEPTOR; LIGAND; PNU 101958; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN MAPPING; DOPAMINE RELEASE; DRUG ACCUMULATION; DRUG RECEPTOR BINDING; HIPPOCAMPUS; MONKEY; NONHUMAN; PREFRONTAL CORTEX; PRIMATE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; QUANTITATIVE DIAGNOSIS; RECEPTOR DENSITY;

AMINOPYRIDINES; ANIMALS; AUTORADIOGRAPHY; BRAIN; HIPPOCAMPUS; MACACA MULATTA; MOLECULAR PROBES; PIPERIDINES; PREFRONTAL CORTEX; PYRIDINES; PYRROLES; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4; TISSUE DISTRIBUTION; TRITIUM;

EID: 0034285002     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2396(20000901)37:3<232::AID-SYN7>3.0.CO;2-7     Document Type: Article

References (81)

1. 4 dopamine receptor protein in the CNS using anti-receptor antisera. Brain Res 752:26-34.
2. Castellanos FX, Lau E, Taybei N, Lee P, Long RE, Giedd JN, Sharp W, Marsh WL, Walter JM, Hamburger SD, Ginns EI, Rapoport JL, Sidransky E. 1998. Lack of association between a dopamine-4 receptor polymorphism and attention-deficit hyperactivity disorder: genetic and brain morphometric analyses. Mol Psychiatry 3:431-434.
3. 4 receptor and response to antipsychotic drugs. Psychopharmacology 141:6-10.
4. Cohen BM, Wan W, Froimowitz MP, Ennulat DJ, Cherkezian S, Konieczna H. 1998. Activation of midline thalamic nuclei by antipsychotic drugs. Psychopharmacology 135:37-43.
5. 4 dopamine receptor in rat brain. Neurochem Res 22: 401-407.
6. 4 dopamine receptor in rat brain with sequence specific antibodies. Mol Brain Res 45:1-12.
7. 4 receptors in non-human primate brain. Soc Neurosci Abstr 23:1137.
8. 3H]tropoxene distributes to dopamine-rich regions of monkey brain. Synapse 34:20-27.
9. 4 receptor (D4DR) exon III repeat polymorphism and the human personality trait of novelty seeking. Mol Psychiatry 2:472-477.
10. Faraone SV, Biederman J. 1998. Neurobiology of attention-deficit hyperactivity disorder. Biol Psychiatry 44:951-958.
11. 4 receptor in the induction of behavioral sensitization to amphetamine and accompanying biochemical and molecular adaptations. J Pharmacol Exp Ther 286:497-508.
12. 4.4 receptor. Br J Pharmacol 124:889-896.
13. 4 dopamine receptor alleles in chronic alcoholism. Biochem Biophys Res Commun 196:107-114.
14. 4 dopamine receptor (DRD4) alleles and novelty seeking in substance-dependent, personality-disorder, and control subjects. Am J Hum Genet 61:1144-1152.
15. 4 receptors and their antagonists. Med Res Rev 16:507-526.
16. Herkenham M. 1987. Mismatches between neurotransmitter and receptor localization in brain: observations and implications. Neuroscience 23:1-38.
17. 4 receptors. Neurosci Lett 186:145-148.
18. 4 dopamine receptor gene in Chinese familial schizophrenic patients. Biol Psychiatry 43:432-435.
19. 4 receptor gene polymorphisms and neuroleptic response in schizophrenia. Biol Psychiatry 44:483-487.
20. Jentsch JD, Taylor JR, Elsworth JD, Redmond DE, Roth RH. 1999a. Altered frontal cortical dopaminergic transmission in monkeys after subchronic phencyclidine exposure: involvement in frontostriatal cognitive deficits. Neuroscience 90:823-832.
21. 4 receptor antagonist reversal of subchronic phencyclidine-induced object retrieval/detour deficits in monkeys. Psychopharmacology 142:78-84.
22. Jentsch JD, Redmond DE, Elsworth JD, Taylor JR, Youngren KD, Roth RH. 1997. Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. Science 277:953-955.
23. Joyce JN, Meador-Woodruff JH. 1997. Linking the family of D2 receptors to neuronal circuits in human brain: insights into schizophrenia. Neuropsychopharmacology 16:375-84.
24. Khan ZU, Gutierrez A, Martin R, Penafiel A, Rivera A, De La Calle A. 1998. Differential regional and cellular distribution of dopamine D2-like receptors: an immunocytochemical study of subtype-specific antibodies in rat and human brain. J Comp Neurol 402:353-71.
25. 4 receptor (D4DR) exon III seven repeat allele in opioid-dependent subjects. Mol Psychiatry 2:251-254.
26. Kramer MS, Last B, Getson A, Reines SA. 1997. The effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia. D4 Dopamine Antagonist Group. Arch Gen Psychiatry 54:567-72.
27. Krieg WJS. 1975. Section atlas of the brain of Macacus Rhesus. Evanston, IL: Brain Books.
28. 4-selective dopamine receptor ligand. Eur J Pharmacol 331:333-336.
29. 4 receptor-selective radioligands. Eur J Pharmacol 367: 139-142.
30. 2-type dopamine receptors in postmortem brain sections from normal and schizophrenic subjects. Neuroreport 7:1945-1948.
31. 3H]NGD-94-1 study. Mol Psychiatry 3:528-533.
32. 4 receptor gene. Health Psychology 17:56-62.
33. 4 gene exon III VNTR and heroin abuse in chinese subjects. Mol Psychiatry 2:413-416.
34. 4 dopamine receptor mRNAs in the primate cerebral cortex vs. neostriatum: Effects of chronic treatment with typical and atypical antipsychotic drugs. J Pharmacol Exp Ther 283:939-946.
35. 4 receptor variants and bipolar affective disorder. Am J Med Genet 54:259-263.
36. 4 receptor (DRD4) gene sequence within and among nonhuman primate species. Proc Natl Acad Sci 92:427-431.
37. 3H]raclopride is increased in schizophrenia. Biol Psychiatry 42:648-654.
38. 4 receptor. Mol Brain Res 29:157-162.
39. 4 receptor are spread over primate species. Biochem Biophys Res Commun 207:467-475.
40. 4 receptor in human cerebral cortex and striatum. J Neurochem 66:915-919.
41. 4 receptor expression in the human striatum. Biol Psychiatry 38:263-266.
42. Meltzer HY, Lee MA, Ranjan R. 1994. Recent advances in the pharmacotherapy of schizophrenia. Acta Psychiatr Scand 90:95-101.
43. Missale C, Russel SR, Robinson SW, Jaber M, Caron MG. 1998. Dopamine receptors: from structure to function. Physiol Rev 78: 189-225.
44. 4 receptors in GABAergic neurons of primate brain. Nature 381:245-248.
45. 4 gene expression in human brain. Neurosci Lett 234:147-150.
46. 4 dopamine receptors in postmortem striatum from patients with schizophrenia. J Neurosci 15:2186-2191.
47. Neve KA, Neve RL. 1997. The Dopamine Receptors. Humana Press, Totowa NJ.
48. 4 distinguen la presencia clinica de tics en el trastorno obsesivo-compulsivo. Gac Med Mex 13:521-527.
49. 3H]nemonapride include substantial serotonin 5-HT2A receptors in primate cerebral cortex. Biochem Biophys Res Commun 255:367-370.
50. 4 receptor. J Pharmacol Exp Ther 283:636-647.
51. 4 receptor gene. Pharmacogenetics 7:345-348.
52. 4 receptor polymorphisms: a twin and genetic association study. Am J Med Genet 81:44-48.
53. 3H]NGD 94-1. J Pharmacol Exp Ther 282:1020-1027.
54. 4 receptor exon 3 repeat polymorphism with Parkinson's disease. Clin Genet 54:33-38.
55. Ritter LM, Meador-Woodruff JH. 1997. Antipsychotic regulation of hippocampal dopamine receptor messenger RNA expression. Biol Psychiatry 42:155-164.
56. Rowe DC, Stever C, Giedinghagen LN, Gard JMC, Cleveland HH, Terris ST, Mohr JH, Sherman S, Abramowitz A, Wladman ID. 1998. Dopamine DRD4 receptor polymorphism and attention deficit hyperactivity disorder. Mol Psychiatry 3:419-426.
57. 4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell 90:991-1001.
58. 4 receptor exon III alleles and variation of novelty seeking in alcoholics. Am J Med Gen 74:483-487.
59. 4 receptors in schizophrenia and antipsychotic action. J Psychiatry Res 31:219-232.
60. 4 receptor. Eur J Pharmacol 322:283-286.
61. 4 receptors elevated in schizophrenia. Nature 365:441-445.
62. Seeman P, Corbett R, Van Tol HH. 1998. Dopamine D4 receptors may alleviate antipsychotic-induced parkinsonism. Adv Pharmacol 42: 478-82.
63. 4 gene is associated with delusional symptomatology in mood disorders. Psychiatry Res 80:129-136.
64. 4 dopamine receptor-mediated phospholipid methylation and its implications for mental illnesses such as schizophrenia. Mol Psychiatry 4:235-46.
65. 4 receptor is a susceptibility gene in attention deficit hyperactivity disorder. Mol Psychiatry 3:427-430.
66. Snider R, Lee JC. 1961. A stereotaxic atlas of the monkey brain (Macaca mulatta). Chicago, IL: University of Chicago Press.
67. 4 dopamine receptor mRNA in postmortem schizophrenic brain. Mol Brain Res 53:112-119.
68. 3H]raclopride binding in postmortem caudate nucleus of sub-jects with schizophrenia or major depression. Brain Res 681:109-16.
69. 4 receptor. Neurosci Lett 199:69-72.
70. Swanson JM, Sunohara GA, Kennedy JL, Regino R, Fineberg E, Wigal T, Lerner M, Williams L, LaHoste GJ, Wigal S. 1998. Association of the dopamine D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach. Mol Psychiatry 3:38-41.
71. Tallman JF. 1998. NGD 94-1: A specific dopamine-4-receptor agonist. Adv Pharmacol 42:490-492.
72. Tallman JF, Primus RJ, Brodbeck R, Cornfield L, Meade R, Woodruff K, Ross P, Thurkauf A, Gallagher DW. 1997. I. NGD 94-1: Identification of a novel, high-affinity antagonist at the human dopamine D4 receptor. J Pharmacol Exp Ther 282:1011-1019.
73. 3H]raclopride in postmortem human brains. Brain Res 765:7-12.
74. 4 receptors in rat forebrain. NeuroReport 8:3423-3426.
75. 4 dopamine receptors: Common targets for typical and atypical antipsychotic drugs. Prog Neuro-Psychopharmacol Biol Psychiat 22:693-707.
76. 4-like receptors. Neuroscience 83:169-176.
77. 4 receptors: significance for molecular psychiatry at the millenium. Mol Psych 4:529-538.
78. 4 receptor (D4DR) exon III seven repeat alleles in Baltimore Longitudinal Study of Aging participants. Mol Psychiatry 2:417-419.
79. 4 receptor with high affinity for the antipsychotic clozapine. Nature 350:610-614.
80. 4 receptor variants in the human population. Nature 358:149-152.
81. 4 receptor ligands: relation to antipsychotic action. Eur J Pharmacol 351:273-286.